☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
VISEN Pharmaceuticals Reports P-III Results of Lonapegsomatropin in Children with Growth Hormone Deficiency
November 17, 2022
Insights+: The US FDA New Drug Approvals in October 2022
November 17, 2022
Ayala Pharmaceuticals Reports First Patient Dosing of AL102 in P-III (RINGSIDE) trial for the Treatment of Desmoid Tumors
November 17, 2022
Horizon Entered into a Multi-Year Scientific Collaboration with Johns Hopkins University School of Medicine to Advance Research in...
November 17, 2022
Mineralys Therapeutics Reports P-II (Target-HTN) Trial Results of MLS-101 for Uncontrolled and Resistant Hypertension
November 17, 2022
Regeneron Entered into a Clinical Supply Agreement with Grey Wolf Therapeutics to Evaluate GRWD5769 + Libtayo (cemiplimab) for Sol...
November 17, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions